MT1‐MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B‐cell development
Guoxiang Jin(Guangdong Academy of Medical Sciences), Zhongjun Zhou(Chinese University of Hong Kong), Kui Ming Chan(City University of Hong Kong), Fengju Zhang(Beijing Tongren Hospital), Kathryn S.E. Cheah(Chinese University of Hong Kong), Cornelia Mauch(University Hospital Cologne), De‐Pei Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Hoi Leong Xavier Wong(Hong Kong Baptist University), Baohua Liu(Shenzhen University), Xinguang Liu(Guangdong Medical College)
Cited by 57
Related Papers
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Genomic instability in laminopathy-based premature aging
|Nature Medicine|2005|641